Joseph D. Barritt

Joseph D. Barritt

Auto-generated profile, based on publicly available information

Joseph D. Barritt

Department of Life Sciences, Imperial College London, London SW7 2AZ, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2024 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SCSerene W. Chen
Serene W. Chen
JBJoseph D. Barritt
Joseph D. Barritt
RCRoberta Cascella
Roberta Cascella
Alessandra BigiAlessandra Bigi
Alessandra Bigi
CCCristina Cecchi
Cristina Cecchi
ASAlfonso De Simone
Alfonso De Simone
The aberrant aggregation of α-synuclein (αS) into amyloid fibrils is associated with a range of highly debilitating neurodegenerative conditions, including Parkinson's disease. Although the structural properties of mature amyloids of αS are currently understood, the nature of transient protofilaments and fibrils that appear during αS aggregation remains elusive. Using solid-state nuclear magnetic resonance (ssNMR), cryogenic electron microscopy (cryo-EM), and biophysical methods, we here characterized intermediate amyloid fibrils of αS forming during the aggregation from liquid-like spherical condensates to mature amyloids adopting the structure of pathologically observed aggregates. These transient amyloid intermediates, which induce significant levels of cytotoxicity when incubated with neuronal cells, were found to be stabilized by a small core in an antiparallel β-sheet conformation, with a disordered N-terminal region of the protein remaining available to mediate membrane binding. In contrast, mature amyloids that subsequently appear during the aggregation showed different structural and biological properties, including low levels of cytotoxicity, a rearranged structured core embedding also the N-terminal region, and a reduced propensity to interact with the membrane. The characterization of these two fibrillar forms of αS, and the use of antibodies and designed mutants, enabled us to clarify the role of critical structural elements endowing intermediate amyloid species with the ability to interact with membranes and induce cytotoxicity.

17 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MSMaximo Sanz-Hernandez
Maximo Sanz-Hernandez
JBJoseph D. Barritt
Joseph D. Barritt
JSJens Sobek
Jens Sobek
SHSimone Hornemann
Simone Hornemann
AAAdriano Aguzzi
Adriano Aguzzi
ASAlfonso De Simone
Alfonso De Simone
Significance: The misfolding and aggregation into amyloid fibrils of the prion protein (PrP) have been strongly linked with a group of neurodegenerative disorders that include the mad cow disease. Currently, the molecular origins of the prion diseases are unknown, including the underlying mechanisms of PrP misfolding and the regions promoting its aggregation. Here, we identified the structural basis by which the folded domain of the human PrP converts into amyloids. We showed that this process is promoted by intermediate species forming as a result of the pathological mutation T183A, and that POM antibodies are able to suppress completely the aggregation process by blocking the misfolding mechanism. This study thereby suggests possible molecular strategies to inhibit PrP aggregation into amyloids.

21 December 2022 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
JHJohn M. Hickey
John M. Hickey
SJShaleem I. Jacob
Shaleem I. Jacob
ATAndrew S. Tait
Andrew S. Tait
FVFatemeh Dastjerdi Vahid
Fatemeh Dastjerdi Vahid
JBJoseph Barritt
Joseph Barritt
Daniel G. BracewellDaniel G. Bracewell
Daniel G. Bracewell
Adenovirus vectors have become an important class of vaccines with the recent approval of Ebola and COVID-19 products. In-process quality attribute data collected during Adenovirus vector manufacturing has focused on particle concentration and infectivity ratios (based on viral genome: cell-based infectivity), and data suggest only a fraction of viral particles present in the final vaccine product are efficacious. To better understand this product heterogeneity, lab-scale preparations of two Adenovirus viral vectors, (Chimpanzee adenovirus (ChAdOx1) and Human adenovirus Type 5 (Ad5), were studied using transmission electron microscopy (TEM). Different adenovirus morphologies were characterized, and the proportion of empty and full viral particles were quantified. These proportions showed a qualitative correlation with the sample's infectivity values. Liquid chromatography-mass spectrometry (LC-MS) peptide mapping was used to identify key adenovirus proteins involved in viral maturation. Using peptide abundance analysis, a ∼5-fold change in L1 52/55k abundance was observed between low-(empty) and high-density (full) fractions taken from CsCl ultracentrifugation preparations of ChAdOx1 virus. The L1 52/55k viral protein is associated with DNA packaging and is cleaved during viral maturation, so it may be a marker for infective particles. TEM and LC-MS peptide mapping are promising higher-resolution analytical characterization tools to help differentiate between relative proportions of empty, non-infectious, and infectious viral particles as part of Adenovirus vector in-process monitoring, and these results are an encouraging initial step to better differentiate between the different product-related impurities.

16 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SSSavvas Saouros
Savvas Saouros
TMThotegowdanapalya C. Mohan
Thotegowdanapalya C. Mohan
CCCristina Cecchetti
Cristina Cecchetti
SLSilke Lehmann
Silke Lehmann
JBJoseph D. Barritt
Joseph D. Barritt
BBBernadette Byrne
Bernadette Byrne
Boron has essential roles in plant growth and development. BOR proteins are key in the active uptake and distribution of boron, and regulation of intracellular boron concentrations. However, their mechanism of action remains poorly studied. BOR proteins are members of the SLC4 family of transporters and thus homologues of well studied mammalian transporters including the human Anion Exchanger 1 (hAE1). Here we generated Arabidopsis thaliana BOR1 (AtBOR1) variants based i) on known disease causing mutations of hAE1 (S466R, A500R) and ii) a loss of function mutation (D311A) identified in the yeast BOR protein, ScBOR1p. The AtBOR1 variants express in yeast and localise to the plasma membrane, although both S466R and A500R exhibit lower expression than the WT AtBOR1 and D311A. The D311A, S466R and A500R mutations result in a loss of boron efflux activity in a yeast bor1p knockout strain. A. thaliana plants containing these three individual mutations exhibit substantially decreased growth phenotypes in soil under conditions of low boron. These data confirm an important role for D311 in the function of the protein and show that mutations equivalent to disease causing mutations in hAE1 have major effects in AtBOR1. We also obtained a low resolution cryo-EM structure of a BOR protein from Oryza sativa , OsBOR3 lacking the 30 C-terminal amino acids. This structure confirms the gate and core domain organisation previously observed for related proteins, and is strongly suggestive of an inward facing conformation.

27 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
QZQi Zhong
Qi Zhong
JBJoseph D Barritt
Joseph D Barritt
ENEmmanuel Nji
Emmanuel Nji
AGAnastasia Gkeka
Anastasia Gkeka
SRSarah L. Rouse
Sarah L. Rouse
CTCalvin Tiengwe
Calvin Tiengwe
Immune evasion in many pathogens relies on sequence variation to generate antigenic diversity. African trypanosomes use an additional strategy where O -glucosylation of variant surface glycoproteins (VSGs) generates heterogeneous glycans that alter antibody epitope recognition, influencing infection outcome. However, the VSG O- glycosylation enzyme has remained unknown. Here, we identify ESAG3 as the glycosyltransferase required for generating these O- glycan-dependent epitopes. ESAG3 depletion in vivo abolishes O- glycosylation-specific monoclonal antibody recognition, while complementation restores binding. ESAG3 has strict UDP-glucose specificity, manganese dependence, and modifies serine/threonine residues within cysteine-flanked VSG peptides. Single-particle cryo-electron microscopy reveals that ESAG3 forms an unprecedented octadecameric architecture with C3 symmetry at 3.4 angstrom resolution, a novel quaternary organisation for a glycosyltransferase. Structure-guided mutagenesis demonstrates essential active-site residues for catalysis, while interface mutations disrupt octadecamer assembly and enhance substrate turnover, indicating that oligomeric architecture regulates catalytic output. This work establishes ESAG3 as a kinetoplastid-specific glucosyltransferase and reveals the molecular basis whereby VSG O -glycosylation generates epitope diversity alongside sequence-based antigenic variation. Significance statement: African trypanosomes evade host immunity by switching variant surface glycoproteins (VSGs) from a vast gene archive, generating extreme antigenic diversity through sequence polymorphism. O -glucosylation adds a second layer where heterogeneous O -linked sugars at the very top of surface-exposed VSG loops diversify the epitope space accessible to host antibodies. We identify ESAG3 as the O- glucosyltransferase responsible for this modification and reveal it forms an unprecedented 18-subunit architecture. Critically, ESAG3 is encoded within VSG expression sites, coupling O -glycosylation to monoallelic transcriptional control. When parasites switch expression sites, VSG sequence changes alongside co-transcribed O -glycosylation machinery, integrating genetic and chemical variation into a unified immune evasion strategy. This work provides the molecular and structural basis for O- glycan-mediated epitope control on the trypanosome surface.

6 October 2026 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
BWBetsy Widdicombe
Betsy Widdicombe
JBJoseph D. Barritt
Joseph D. Barritt
NPNichakorn Pipatpadungsin
Nichakorn Pipatpadungsin
BSBraulio Carrillo Sanchez
Braulio Carrillo Sanchez
DSDale Stibbs
Dale Stibbs
Daniel G. BracewellDaniel G. Bracewell
Daniel G. Bracewell
Vaccines and gene therapies require efficient delivery of genetic material to host cells. Viral vectors leverage viruses' ability to enter host cells to achieve this. Following the SARS‐CoV‐2 vaccine and novel gene therapies that utilize adenovirus vectors, there has been an increase in the demand for large‐scale production of vectors. A benefit of adenovirus vectors is that they can act as a “plug and play” tool for any future emerging diseases for the development of vaccines. A key obstacle was the heterogeneity that is found in the final product. This can reduce the functionality of the vector and affect immune responses. A possible origin of heterogeneity is the downstream processing, specifically the bind and elute steps of anion exchange chromatography (AEX), which is widely used at scale. To better understand the heterogeneity that AEX could elicit on the adenovirus capsid, cryogenic‐electron tomography was used to assess the capsid integrity after a variety of chromatography conditions in comparison to a cesium chloride (CsCl) gradient ultracentrifugation purified control. To investigate the effect of absorption time during chromatography, AEX conditions with a 5, 10, and 20 min on‐resin absorption periods were evaluated. Following AEX binding at pH 6.5, samples showed a reduction from 17% in the CsCl purified control to 10% infectious particles. When examined using electron microscopy, the virions exhibited aggregation and a decrease from 70% to 54% in fiber occupancy. After a 20 min AEX hold at pH 6.5 there was almost complete loss of infectivity and fiber occupancy decreased from ~70% to below 30%. Samples run at pH 8 did not show the same loss in infectivity when held bound for 20 min. This suggests that purification conditions can cause removal of the fiber protein, which was likely causing the decrease in infectivity, due to the fiber's role in cell entry. We hypothesize that fiber removal was caused by a combination of hold time and weakened binding between the fiber and penton base due to the low pH conditions that are often used during AEX. This work demonstrates a link between fiber loss and reduced adenovirus vector functionality and how purification conditions can impact vector functionality. Through studying the relationship between structure and function, we can hopefully minimize loss of infectivity during purification by optimizing processing conditions, reduce manufacturing cost and improve the quality of adenovirus vaccines and gene therapies.